Add Yahoo as a preferred source to see more of our stories on Google. A medical team performs a conventional kidney transplant in an undated photo, but a bio-engineered kidney soon might be available ...

REDWOOD CITY, Calif., March 17, 2026 (GLOBE NEWSWIRE) -- R1 Therapeutics, Inc (“R1”), a clinical-stage biopharmaceutical company focused on the development of first-in-class therapies for patients ...

Renasant Bio has launched with $54.5 million in seed financing to develop treatments for autosomal dominant polycystic kidney disease (ADPKD), which causes severe kidney damage. The financing was led ...

Antibody-mediated rejection (ABMR) remains the leading immunological cause of kidney allograft loss, yet its humoral origins are incompletely understood.

April 15 (UPI) --A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from the hospital in February, according to biotech firm ...